Cambridge, Massachusetts, May 3, 2024–(BUSINESS WIRE)–2seventy bio, Inc. (Nasdaq: TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. The conference call and webcast will be held at 8 a.m. ET.
Participants will have access to the conference call live via the webcast, which will be available on the Investors and Media page of the Company's website at https://ir.2seventybio.com. Participants who wish to ask questions can register here to receive a dial-in number and unique PIN to join the call. Participants are encouraged to join 10 minutes before the start of the event. A replay of the call will be available on his website at 2seventy bio after the call ends.
270 Biography
Our name, 2seventy bio, reflects what we do: time. Cancer steals your time. Our goal is to work at 270 miles per hour, the highest speed at which human thought can be translated into action, to give more time to the people we serve. With a deep understanding of the human body's immune response to tumor cells and how to implement cell therapy, we are applying this knowledge to bring the first FDA-approved CAR T-cell therapy for multiple myeloma to as many patients as possible. It offers. Importantly, we remain true and authentic to our “why” and remain focused on achieving our mission by keeping our people and culture top of mind every day.
For more information, please visit www.2seventybio.com.
Follow 2seventy's profile on social media: X (Twitter) And LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source version on businesswire.com. https://www.businesswire.com/news/home/20240503081790/ja/
contact address
Investor:
Vicki Eatwell, CFO
vicki.eatwell@2seventybio.com
jen snyder
Jenn.snyder@2seventybio.com
media:
jen snyder
Jenn.snyder@2seventybio.com
